Protection Purchased on Chelsea Therapeutics (CHTP)

Shares of Chelsea Therapeutics International, Ltd.

are higher on the session by 3.52%, currently trading at $5.30. The stock has been moving largely higher over the past six months, popping off of a base near $2.75. Options traders seem to be worried about a return to those levels, though. A short while ago the March 2011 $2.50 put was purchased 4,261 times, near the offer, for an average price of ~$0.28. This has pushed overall put volume to 2.7x the daily average. Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases. The Company is developing a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension, and related conditions and diseases along with its development of prescription products for multiple autoimmune disorders, including rheumatoid arthritis, psoriasis, inflammatory bowel disease and cancer. For more great research like this, as well as how to play it through options…please visit

and

.